CDC42EP2 and acute myeloid leukemia: Furthermore, we have generalized our methodology and applied our investigations to AML, which identified three AML-specific genes (CDC42EP2, CDC42, and ALOX15B) with significant ability to predict AML overall survival, especially for patients with favorable cytogenetic risk and for patients of older chronological age.